Literature DB >> 21887730

Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1.

Yun Zhao1, Carmen Alonso, Isabel Ballester, Joo Hye Song, Sun Young Chang, Bayasi Guleng, Seiji Arihiro, Peter J Murray, Ramnik Xavier, Koichi S Kobayashi, Hans-Christian Reinecker.   

Abstract

BACKGROUND: Genetic variants of nucleotide-binding oligomerization domain 2 (NOD2) lead to aberrant microbial recognition and can cause chronic inflammatory diseases in patients with Crohn's disease (CD).
METHODS: We utilized gene-specific siRNA mediated knockdown and expression of guanine nucleotide exchange factor H1 (GEF-H1) in wildtype, Rip2-, and Nod2-deficient macrophages, HCT-116 and HEK 293 cells to determine the role of GEF-H1 in NOD2 and Rip2-mediated NF-κB-dependent induction of proinflammatory cytokine expression. Confocal microscopy was used to determine subcellular distribution of GEF-H1, Rip2, and NOD2.
RESULTS: We identified GEF-H1 as an unexpected component of innate immune regulation during microbial pattern recognition by NOD2. Surprisingly, GEF-H1-mediated the activation of Rip2 during signaling by NOD2, but not in the presence of the 3020 insC variant of NOD2 associated with CD. GEF-H1 functioned downstream of NOD2 as part of Rip2-containing signaling complexes and was responsible for phosphorylation of Rip2 by Src tyrosine kinase. Rip2 variants lacking the tyrosine target of GEF-H1-mediated phosphorylation were unable to mediate NF-κB activation in Rip2-deficient macrophages and failed to transduce NOD2 signaling. GEF-H1 is required downstream of NOD2 as part of Rip2-containing signaling complexes for the activation of innate immune responses.
CONCLUSIONS: GEF-H1 connects tyrosine kinase function to NOD-like receptor signaling and is fundamental to the regulation of microbial recognition by ubiquitous innate immune mechanisms mediated by Rip2 kinase.
Copyright © 2011 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21887730      PMCID: PMC3594873          DOI: 10.1002/ibd.21851

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  43 in total

1.  CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis.

Authors:  P Rahman; S Bartlett; F Siannis; F J Pellett; V T Farewell; L Peddle; C T Schentag; C A Alderdice; S Hamilton; M Khraishi; Y Tobin; D Hefferton; D D Gladman
Journal:  Am J Hum Genet       Date:  2003-07-23       Impact factor: 11.025

2.  Large-scale proteomics analysis of the human kinome.

Authors:  Felix S Oppermann; Florian Gnad; Jesper V Olsen; Renate Hornberger; Zoltán Greff; György Kéri; Matthias Mann; Henrik Daub
Journal:  Mol Cell Proteomics       Date:  2009-04-15       Impact factor: 5.911

3.  Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum.

Authors:  Amlan Biswas; Yuen-Joyce Liu; Liming Hao; Atsushi Mizoguchi; Nita H Salzman; Charles L Bevins; Koichi S Kobayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

4.  Innate signals from Nod2 block respiratory tolerance and program T(H)2-driven allergic inflammation.

Authors:  Wei Duan; Amit K Mehta; Joao G Magalhaes; Steven F Ziegler; Chen Dong; Dana J Philpott; Michael Croft
Journal:  J Allergy Clin Immunol       Date:  2010-11-04       Impact factor: 10.793

5.  Cooperation between multiple microbial pattern recognition systems is important for host protection against the intracellular pathogen Legionella pneumophila.

Authors:  Kristina A Archer; Florence Ader; Koichi S Kobayashi; Richard A Flavell; Craig R Roy
Journal:  Infect Immun       Date:  2010-03-29       Impact factor: 3.441

6.  Inhibition of RIP2's tyrosine kinase activity limits NOD2-driven cytokine responses.

Authors:  Justine T Tigno-Aranjuez; John M Asara; Derek W Abbott
Journal:  Genes Dev       Date:  2010-12-01       Impact factor: 11.361

7.  The src family-selective tyrosine kinase inhibitor PP1 blocks LPS and IFN-gamma-mediated TNF and iNOS production in murine macrophages.

Authors:  S L Orlicek; J H Hanke; B K English
Journal:  Shock       Date:  1999-11       Impact factor: 3.454

8.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Authors:  J P Hugot; M Chamaillard; H Zouali; S Lesage; J P Cézard; J Belaiche; S Almer; C Tysk; C A O'Morain; M Gassull; V Binder; Y Finkel; A Cortot; R Modigliani; P Laurent-Puig; C Gower-Rousseau; J Macry; J F Colombel; M Sahbatou; G Thomas
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

9.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

10.  Activation of NOD2-mediated intestinal pathway in a pediatric population with Crohn's disease.

Authors:  Anna Negroni; Laura Stronati; Maria Pierdomenico; Donatella Tirindelli; Giovanni Di Nardo; Valentina Mancini; Giulia Maiella; Salvatore Cucchiara
Journal:  Inflamm Bowel Dis       Date:  2009-08       Impact factor: 5.325

View more
  21 in total

Review 1.  NOD proteins: regulators of inflammation in health and disease.

Authors:  Dana J Philpott; Matthew T Sorbara; Susan J Robertson; Kenneth Croitoru; Stephen E Girardin
Journal:  Nat Rev Immunol       Date:  2013-12-13       Impact factor: 53.106

Review 2.  Go with the flow: GEF-H1 mediated shear stress mechanotransduction in neutrophils.

Authors:  Noah Fine; Ioannis D Dimitriou; Robert Rottapel
Journal:  Small GTPases       Date:  2017-11-30

Review 3.  NOD1 and NOD2: Beyond Peptidoglycan Sensing.

Authors:  A Marijke Keestra-Gounder; Renée M Tsolis
Journal:  Trends Immunol       Date:  2017-08-16       Impact factor: 16.687

4.  Guanine nucleotide exchange factor -H1 promotes inflammatory cytokine production and intracellular mycobacterial elimination in macrophages.

Authors:  Hui Wang; Jinli Wang; Jiahui Yang; Xiaofan Yang; Jianchun He; Ruining Wang; Sudong Liu; Lin Zhou; Li Ma
Journal:  Cell Cycle       Date:  2017-08-07       Impact factor: 4.534

5.  The Regulatory Subunit PPP2R2A of PP2A Enhances Th1 and Th17 Differentiation through Activation of the GEF-H1/RhoA/ROCK Signaling Pathway.

Authors:  Wenliang Pan; Kamalpreet Nagpal; Abel Suárez-Fueyo; Andrew Ferretti; Nobuya Yoshida; Maria G Tsokos; George C Tsokos
Journal:  J Immunol       Date:  2021-03-24       Impact factor: 5.422

6.  Contribution of Human Fibroblasts and Endothelial Cells to the Hallmarks of Inflammation as Determined by Proteome Profiling.

Authors:  Astrid Slany; Andrea Bileck; Dominique Kreutz; Rupert L Mayer; Besnik Muqaku; Christopher Gerner
Journal:  Mol Cell Proteomics       Date:  2016-03-29       Impact factor: 5.911

Review 7.  Detection of enteric pathogens by the nodosome.

Authors:  A Marijke Keestra; Andreas J Bäumler
Journal:  Trends Immunol       Date:  2013-11-22       Impact factor: 16.687

8.  Oviduct as a sensor of embryo quality: deciphering the extracellular vesicle (EV)-mediated embryo-maternal dialogue.

Authors:  Keerthie Dissanayake; Monika Nõmm; Freddy Lättekivi; James Ord; Yosra Ressaissi; Kasun Godakumara; Qurat Ul Ain Reshi; Janeli Viil; Kersti Jääger; Agne Velthut-Meikas; Andres Salumets; Ülle Jaakma; Alireza Fazeli
Journal:  J Mol Med (Berl)       Date:  2021-01-29       Impact factor: 4.599

9.  Inference about causation between body mass index and DNA methylation in blood from a twin family study.

Authors:  Shuai Li; Ee Ming Wong; Minh Bui; Tuong L Nguyen; Ji-Hoon Eric Joo; Jennifer Stone; Gillian S Dite; Pierre-Antoine Dugué; Roger L Milne; Graham G Giles; Richard Saffery; Melissa C Southey; John L Hopper
Journal:  Int J Obes (Lond)       Date:  2018-05-17       Impact factor: 5.095

Review 10.  The cytoskeleton in cell-autonomous immunity: structural determinants of host defence.

Authors:  Serge Mostowy; Avinash R Shenoy
Journal:  Nat Rev Immunol       Date:  2015-08-21       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.